EZH2 and cancer: Moreover, we found that combined treatment of cells with SAHA and EZH2 inhibitors induced cellular senescence via the suppression of CCF production, resulting in the inhibition of SASP secretion and the enhancement of the cancer-suppressing effect of SAHA in SCLC cells.